Eddy Pharmaceuticals: Eddy Pharmaceuticals Voluntary Disclosure Notice on Approval of the Marketing Application for New Indications of Enomie Tablets
Eddy Pharmaceuticals Voluntary Disclosure Notice on Approval of the Marketing Application for New Indications of Enomide Tablets
Eddy Pharmaceuticals: Eddy Pharmaceuticals Progress Notice on Major Asset Restructurings
Eddy Pharmaceutical\'s progress announcement on major asset restructuring matters
Addy Pharmaceuticals: Addy Pharmaceuticals Voluntary Disclosure Notice on Withdrawal of the Marketing Application for New Indications of Anovirin Tablets
Addy Pharmaceuticals Voluntary Disclosure Notice on Withdrawal of the Marketing Application for New Indications of Anovirin Tablets
Jiangsu Eddy Pharmaceutical Co., Ltd. Major Asset Purchase Implementation Report
Legal opinion of Jiangsu Century Tongren Law Firm on the implementation of major asset purchases of Jiangsu Eddy Pharmaceutical Co., Ltd.
Independent financial advisory opinion of Minsheng Securities Co., Ltd. on the implementation of major asset purchases by Jiangsu Eddy Pharmaceutical Co., Ltd.
Eddy Pharmaceutical\'s announcement on the completion of the asset transfer of the object of the major asset purchase
Eddy Pharmaceuticals: Eddy Pharmaceuticals Announcement on Pledging Shares in Holding Subsidiaries
Eddy Pharmaceuticals: Announcement of Resolutions of the 25th Meeting of the 2nd Board of Supervisors of Eddy Pharmaceuticals
Announcement of Resolutions of the 25th Meeting of the 2nd Board of Supervisors of Eddy Pharmaceuticals
Eddy Pharmaceuticals Announcement on Pledging Shares in Holding Subsidiaries
Eddy Pharmaceuticals Announcement on Participating in the 2024 Semi-Annual Science and Technology Innovation Board Special Group Performance Briefing on Pharmaceuticals and Biological Products
Eddy Pharmaceutical\'s announcement on applying for bank credit lines
Eddy Pharmaceutical\'s announcement on the plan for the company\'s directors and senior management to reduce their shareholding through centralized bidding
Eddy Pharmaceuticals Investor Relations Activity Record Form (2024-003)
Eddy Pharmaceutical\'s progress announcement on major asset restructuring matters
Notice of Subscription Agreement and Related Party Transaction Signed by Jiangsu Aidea Pharmaceuticals with Specific Party Subject to Certain Conditions
No Data
No Data